284 related articles for article (PubMed ID: 22487493)
1. Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy.
Gu JW; Rizzo P; Pannuti A; Golde T; Osborne B; Miele L
Vasc Cell; 2012 Apr; 4():7. PubMed ID: 22487493
[TBL] [Abstract][Full Text] [Related]
2. Dll4-Notch signaling as a therapeutic target in tumor angiogenesis.
Kuhnert F; Kirshner JR; Thurston G
Vasc Cell; 2011 Sep; 3(1):20. PubMed ID: 21923938
[TBL] [Abstract][Full Text] [Related]
3. Targeting Notch to target cancer stem cells.
Pannuti A; Foreman K; Rizzo P; Osipo C; Golde T; Osborne B; Miele L
Clin Cancer Res; 2010 Jun; 16(12):3141-52. PubMed ID: 20530696
[TBL] [Abstract][Full Text] [Related]
4. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
5. Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective.
Akil A; Gutiérrez-García AK; Guenter R; Rose JB; Beck AW; Chen H; Ren B
Front Cell Dev Biol; 2021; 9():642352. PubMed ID: 33681228
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
7. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.
Merk H; Zhang S; Lehr T; Müller C; Ulrich M; Bibb JA; Adams RH; Bracher F; Zahler S; Vollmar AM; Liebl J
Oncotarget; 2016 Feb; 7(5):6088-104. PubMed ID: 26755662
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in cancer - general pathways and their therapeutic implications.
Dimova I; Popivanov G; Djonov V
J BUON; 2014; 19(1):15-21. PubMed ID: 24659637
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis.
Liu ZJ; Shirakawa T; Li Y; Soma A; Oka M; Dotto GP; Fairman RM; Velazquez OC; Herlyn M
Mol Cell Biol; 2003 Jan; 23(1):14-25. PubMed ID: 12482957
[TBL] [Abstract][Full Text] [Related]
11. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
[TBL] [Abstract][Full Text] [Related]
12. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
Guo S; Gonzalez-Perez RR
PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling.
Zhu X; Ding S; Qiu C; Shi Y; Song L; Wang Y; Wang Y; Li J; Wang Y; Sun Y; Qin L; Chen J; Simons M; Min W; Yu L
Circ Res; 2017 Sep; 121(6):636-649. PubMed ID: 28760777
[TBL] [Abstract][Full Text] [Related]
15. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
Du FY; Zhou QF; Sun WJ; Chen GL
World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
[TBL] [Abstract][Full Text] [Related]
16. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours.
Beck B; Driessens G; Goossens S; Youssef KK; Kuchnio A; Caauwe A; Sotiropoulou PA; Loges S; Lapouge G; Candi A; Mascre G; Drogat B; Dekoninck S; Haigh JJ; Carmeliet P; Blanpain C
Nature; 2011 Oct; 478(7369):399-403. PubMed ID: 22012397
[TBL] [Abstract][Full Text] [Related]
17. Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1.
Folkins C; Shaked Y; Man S; Tang T; Lee CR; Zhu Z; Hoffman RM; Kerbel RS
Cancer Res; 2009 Sep; 69(18):7243-51. PubMed ID: 19738068
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches to target cancer stem cells.
Diaz A; Leon K
Cancers (Basel); 2011 Aug; 3(3):3331-52. PubMed ID: 24212957
[TBL] [Abstract][Full Text] [Related]
19. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
Muñoz-Galván S; Felipe-Abrio B; García-Carrasco M; Domínguez-Piñol J; Suarez-Martinez E; Verdugo-Sivianes EM; Espinosa-Sánchez A; Navas LE; Otero-Albiol D; Marin JJ; Jiménez-García MP; García-Heredia JM; Quiroga AG; Estevez-Garcia P; Carnero A
J Exp Clin Cancer Res; 2019 Jun; 38(1):234. PubMed ID: 31159852
[TBL] [Abstract][Full Text] [Related]
20. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
